Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Hum Reprod ; 38(3): 482-488, 2023 03 01.
Article in English | MEDLINE | ID: mdl-36644915

ABSTRACT

Approximately 50% of transmasculine people use testosterone for gender affirmation, yet very little is known about the effects of testosterone on future reproductive capacity. Moreover, there are no data to guide fertility specialists on how to manage testosterone leading up to or during ovarian stimulation. Most clinics require cessation of testosterone prior to ovarian stimulation in this setting of no data; however, the current literature does suggest a potential increase in dysphoria with cessation of testosterone and during stimulation. This divergence begs the question of whether clinicians may be doing more harm than good by enacting this requirement. Here, we present two cases of transmasculine individuals who were on testosterone prior to stimulation and maintained their testosterone dosage throughout stimulation as proof of concept, followed by a discussion of current clinical practice and providing some rationale to support continuation of testosterone throughout stimulation.


Subject(s)
Testosterone , Transgender Persons , Humans , Reproduction , Gender Identity , Ovulation Induction
2.
BMC Vet Res ; 16(1): 477, 2020 Dec 08.
Article in English | MEDLINE | ID: mdl-33292200

ABSTRACT

Induced pluripotent stem cells (iPSCs) are undifferentiated stem cells characterized by the ability to differentiate into any cell type in the body. iPSCs are a relatively new and rapidly developing technology in many fields of biology, including developmental anatomy and physiology, pathology, and toxicology. These cells have great potential in research as they are self-renewing and pluripotent with minimal ethical concerns. Protocols for their production have been developed for many domestic animal species, which have since been used to further our knowledge in the progression and treatment of diseases. This research is valuable both for veterinary medicine as well as for the prospect of translation to human medicine. Safety, cost, and feasibility are potential barriers for this technology that must be considered before widespread clinical adoption. This review will analyze the literature pertaining to iPSCs derived from various domestic species with a focus on iPSC production and characterization, applications for tissue and disease research, and applications for disease treatment.


Subject(s)
Cell Differentiation , Induced Pluripotent Stem Cells/cytology , Animals , Animals, Domestic , Cell Culture Techniques/methods , Cell Culture Techniques/veterinary , Induced Pluripotent Stem Cells/physiology , Regenerative Medicine/methods , Veterinary Medicine/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...